NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 51 filers reported holding NEUBASE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $57,924 | -2.7% | 313,100 | 0.0% | 0.07% | -5.6% |
| Q4 2022 | $59,552 | -68.0% | 313,100 | -33.5% | 0.07% | -64.4% |
| Q3 2022 | $186,000 | -62.3% | 470,524 | 0.0% | 0.20% | -59.5% |
| Q2 2022 | $494,000 | -38.4% | 470,524 | +10.3% | 0.50% | +2.3% |
| Q1 2022 | $802,000 | -33.1% | 426,424 | 0.0% | 0.49% | -8.8% |
| Q4 2021 | $1,198,000 | -18.6% | 426,424 | +4.6% | 0.54% | 0.0% |
| Q3 2021 | $1,471,000 | -11.1% | 407,500 | +17.9% | 0.54% | -2.0% |
| Q2 2021 | $1,655,000 | -4.9% | 345,500 | +46.7% | 0.55% | -19.0% |
| Q1 2021 | $1,740,000 | +140.7% | 235,500 | +127.5% | 0.67% | +23.2% |
| Q4 2020 | $723,000 | – | 103,500 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 906,445 | $3,272,000 | 1.04% |
| Greenlight Capital | 2,727,027 | $9,844,000 | 0.66% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 407,500 | $1,471,000 | 0.54% |
| CM Management, LLC | 75,000 | $271,000 | 0.20% |
| Stonepine Capital Management, LLC | 109,742 | $396,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 351,178 | $1,268,000 | 0.13% |
| PERKINS CAPITAL MANAGEMENT INC | 21,000 | $76,000 | 0.05% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $1,123,000 | 0.03% |
| Polar Asset Management Partners Inc. | 634,618 | $2,291,000 | 0.02% |
| Point72 Asset Management, L.P. | 1,250,000 | $4,513,000 | 0.02% |